Mettler-Toledo International (NYSE:MTD) Given New $1,400.00 Price Target at Citigroup

Mettler-Toledo International (NYSE:MTD) had its price target decreased by Citigroup from $1,450.00 to $1,400.00 in a research note released on Tuesday,Benzinga reports. Citigroup currently has a neutral rating on the medical instruments supplier’s stock.

A number of other brokerages also recently commented on MTD. Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $1,380.50.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,242.44 on Tuesday. The stock has a fifty day moving average of $1,291.82 and a two-hundred day moving average of $1,326.68. The company has a market capitalization of $25.99 billion, a price-to-earnings ratio of 30.65, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International has a fifty-two week low of $1,142.91 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently bought and sold shares of the company. SBI Securities Co. Ltd. bought a new stake in Mettler-Toledo International in the fourth quarter valued at about $33,000. Ashton Thomas Securities LLC bought a new stake in Mettler-Toledo International in the third quarter valued at about $37,000. Edmond DE Rothschild Holding S.A. bought a new stake in Mettler-Toledo International in the fourth quarter valued at about $44,000. Blue Trust Inc. increased its holdings in Mettler-Toledo International by 70.8% in the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after buying an additional 17 shares during the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in Mettler-Toledo International in the fourth quarter valued at about $54,000. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.